Oral Session 2-9B CML: Clinical trials

[OS2-9B-1] Long term efficacy of TKI therapy for chronic myeloid leukemia; a single center experience

Emiko Sakaida¹, Jun Takiguchi¹, Chikako Ohwada¹, Takaaki Tanami¹, Yasuhito Hatanaka¹, Arata Ishii¹, Miki Yamazaki¹, Yurie Nagai¹, Tatsuzo Mishina¹, Yutaro Hino¹, Koji Takaishi¹, Yusuke Isshiki¹, Kenji Kimura¹, Kensuke Kayamori¹, Nagisa Oshima¹, Shokichi Tsukamoto¹, Shio Mitsukawa^1,2, Yusuke Takeda¹, Naoya Mimura^1,2, Masahiro Takeuchi¹, Tohru Iseki^1,2, Chiaki Nakaseko^1,3 (1.Department of Hematology, Chiba University Hospital, 2.Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, 3.Department of Hematology, International University of Health and Welfare, Narita)